1118290

Robert E. Litman, M.D. — FEI 3005473403

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 20, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Gaithersburg, MD (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance